脑心通胶囊联合阿司匹林与氯吡格雷治疗急性缺血性中风的效果观察

Effect of Naoxintong Capsule combined with aspirin, clopidogrel on acute ischemic stroke

  • 摘要:
      目的  探讨脑心通胶囊联合阿司匹林与氯吡格雷治疗急性缺血性中风的效果。
      方法  选取96例急性缺血性中风患者进行研究,以随机数字表法将其分为对照组与观察组各48例,对照组采用阿司匹林与氯吡格雷治疗,观察组在对照组基础上加用脑心通胶囊治疗,对2组患者的治疗效果、血尿酸(UA)、B细胞淋巴瘤-2基因(Bcl-2)、Bcl-2相关X蛋白(BAX)水平、神经功能评分进行观察。
      结果  观察组、对照组的治疗总有效率分别为95.83%、81.25%, 组间差异显著(P < 0.05); 治疗前, 2组的UA、BAX、Bcl-2水平无显著差异(P>0.05),治疗后2组均显著改善,且观察组较对照组改善更显著(P < 0.05); 治疗后,观察组的改良Rankin量表(mRS)、美国国立卫生院神经功能缺损评分量表(NIHSS)评分与对照组比较有显著差异(P < 0.05)。
      结论  脑心通胶囊联合阿司匹林与氯吡格雷治疗急性缺血性中风效果满意,能改善患者神经功能,调节UA、BAX、Bcl-2蛋白水平。

     

    Abstract:
      Objective  To explore the effect of Naoxintong Capsule combined with aspirin and clopidogrel in the treatment of acute ischemic stroke.
      Methods  A total of 96 patients with acute ischemic stroke who were admitted in our hospital were selected as subjects. According to the random number table method, they were divided into control group(n=48) and observation group(n=48). The control group was treated with aspirin and clopidogrel, while the observation group was treated with Naoxintong Capsule on the basis of the control group. The treatment efficacy, blood uric acid (UA), B cell lymphoma-2 gene(Bcl-2), X protein related to Bcl-2(BAX), neurological function score of the two groups were observed.
      Results  The total effective rate of the observation group and the control group was 95.83% and 81.25%, respectively, and the difference was significant (P < 0.05). There were no significant differences in the levels of UA, BAX and BCL-2 between the two groups before treatment (P>0.05), the above indicators were significantly improved after treatment, and the observation group was better than the control group (P < 0.05). The modified Rankin Scale score(mRS) and National Institutes of Health Neurologic Impairment Scale (NIHSS) scores of the observation group showed significant between group differences(P < 0.05).
      Conclusion  Naoxintong Capsule combined with aspirin and clopidogrel are effective in treating acute ischemic stroke, which can improve neurological function and regulate UA, BAX and BCL-2 protein levels.

     

/

返回文章
返回